ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Small Cell Lung Carcinoma
Carcinoma
Colorectal Cancer
Squamous Cell Carcinoma of Head and Neck
Neoplasm Metastasis

Lung Cancer trials near Budapest, Budapest, HUN:

Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2)

Probe Breath Biopsy Test to differentiate between individuals with lung cancer and relevant contrast groups.The contrast groups wil...

Enrolling
Lung Cancer
Diagnostic Test: OWL-EVO1

Phase 2

Owlstone Medical

Budapest, Hungary and 8 other locations

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Budapest, Hungary and 84 other locations

to docetaxel in participants with advanced non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have been previous...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: JDQ443
Drug: docetaxel

Phase 3

Novartis
Novartis

Budapest, Hungary and 52 other locations

Locations recently updated

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Docetaxel
Drug: DS-1062a

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Budapest, Hungary and 210 other locations

Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common fo ...

Enrolling
Non-small Cell Lung Cancer
Drug: Pemetrexed
Biological: HER3-DXd

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Budapest, Hungary and 36 other locations

resectable, early-stage non-small cell lung cancer....

Enrolling
Non-small Cell Lung Cancer
Drug: Cisplatin
Drug: Rilvegostomig

Phase 2

AstraZeneca
AstraZeneca

Törökbálint, Hungary and 97 other locations

In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin®. The aim of the study is to demon...

Active, not recruiting
Non-small Cell Lung Cancer
Lung Cancer
Drug: Bevacizumab
Drug: Carboplatin

Phase 3

Prestige Biopharma

Törökbálint, Hungary and 17 other locations

with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Carboplatin

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Budapest, Hungary and 254 other locations

The primary objective of this study is to evaluate the safety and tolerability of tarlatamab in combination with YL201 with or without anti-PD-L1.

Enrolling
Small Cell Lung Cancer
Drug: Tarlatamab
Drug: Durvalumab

Phase 1

Amgen
Amgen

Gyöngyös, Hungary and 20 other locations

of Serplulimab + chemotherapy+ concurrent radiotherapy vs chemotherapy+ concurrent radiotherapy in subjects with Limited-Stage Small Cell Lung...

Active, not recruiting
Limited-Stage Small Cell Lung Cancer
Drug: carboplatin/cisplatin-etoposide
Drug: Placebo

Phase 3

Henlius Pharmaceuticals

Torokbalint, Hungary and 128 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems